Contact-dependent growth inhibition (CDI) is a widespread mechanism of bacterial competition. CDI + bacteria deliver the toxic C-terminal region of contact-dependent inhibition A proteins (CdiA-CT) into neighboring target bacteria and produce CDI immunity proteins (CdiI) to protect against self-inhibition. The CdiA-CT EC536 deployed by uropathogenic Escherichia coli 536 (EC536) is a bacterial toxin 28 (Ntox28) domain that only exhibits ribonuclease activity when bound to the cysteine biosynthetic enzyme O-acetylserine sulfhydrylase A (CysK).
Here, we present crystal structures of the CysK/CdiA-CT EC536 binary complex and the neutralized ternary complex of CysK/CdiA-CT/ CdiI EC536 . CdiA-CT EC536 inserts its C-terminal Gly-Tyr-Gly-Ile peptide tail into the active-site cleft of CysK to anchor the interaction. Remarkably, E. coli serine O-acetyltransferase uses a similar Gly-Asp-Gly-Ile motif to form the "cysteine synthase" complex with CysK. The cysteine synthase complex is found throughout bacteria, protozoa, and plants, indicating that CdiA-CT EC536 exploits a highly conserved protein-protein interaction to promote its toxicity. CysK significantly increases CdiA-CT EC536 thermostability and is required for toxin interaction with tRNA substrates. These observations suggest that CysK stabilizes the toxin fold, thereby organizing the nuclease active site for substrate recognition and catalysis. By contrast, Ntox28 domains from Gram-positive bacteria lack C-terminal Gly-Tyr-Gly-Ile motifs, suggesting that they do not interact with CysK. We show that the Ntox28 domain from Ruminococcus lactaris is significantly more thermostable than CdiA-CT EC536 , and its intrinsic tRNA-binding properties support CysK-independent nuclease activity. The striking differences between related Ntox28 domains suggest that CDI toxins may be under evolutionary pressure to maintain low global stability.
bacterial competition | structural biology | toxin chaperone | tRNase activity B acteria have evolved diverse mechanisms to communicate and compete with neighboring microorganisms. One such mechanism is contact-dependent growth inhibition (CDI), which mediates the transfer of protein toxins between Gram-negative bacterial cells. CDI systems are distributed throughout α-, β-, and γ-proteobacteria and are particularly common in pathogens (1) . CDI is mediated by the CdiB/CdiA family of two-partner secretion proteins. CdiB is an Omp85-family transporter that exports and assembles CdiA effectors onto the cell surface. CdiA proteins share homology with filamentous hemagglutinin adhesins and are thought to form long filaments projecting from the inhibitor cell. CdiA recognizes specific receptors on susceptible bacteria and delivers its toxic C-terminal domain (CdiA-CT) to inhibit target-cell growth (2) . CDI + bacteria also produce CdiI immunity proteins, which bind CdiA-CT domains and neutralize their toxic activity to protect against self-inhibition. The CdiA-CT region is highly polymorphic between bacteria, with sequences diverging abruptly after the Val-Glu-Asn-Asn (VENN) peptide motif within the conserved pretoxin domain (Pfam: PF04829) (3, 4) . CdiA-CT diversity reflects the variety of toxins deployed during CDI, with most experimentally characterized toxins exhibiting distinct nuclease activities (3, 5-7). CdiI immunity proteins are also variable and only neutralize their cognate CdiA-CT toxins. Thus, CDI is thought to mediate interstrain competition, with toxin/immunity protein variability providing a mechanism to discriminate between self and non-self (1, 2) .
Previous studies on the CDI toxin from uropathogenic Escherichia coli 536 (EC536) revealed that it possesses latent anticodon nuclease activity against all tRNA isoacceptors (8). The CdiA-CT EC536 region is composed of two domains that have distinct functions during CDI (9) . The extreme C-terminal domain is an Ntox28 RNase family member (Pfam: PF15605) and is responsible for growth-inhibition activity (3, 8) . The N-terminal domain facilitates translocation of the tethered nuclease into the cytosol of target bacteria (9) . Although CdiA-CT EC536 rapidly cleaves tRNA in vivo, the purified toxin has no detectable nuclease activity in vitro (8) . Using biochemical approaches, we discovered that CdiA-CT EC536 is activated when bound to the biosynthetic enzyme O-acetylserine sulfhydrylase-A (CysK). CysK is one of two isoenzymes (along with CysM) that catalyze the final reaction in cysteine synthesis. In bacteria and plants, CysK is found in the "cysteine synthase" complex together with CysE-the serine O-acetyltransferase responsible for the penultimate step of cysteine synthesis (10) . Formation of the cysteine synthase complex requires the C-terminal tail of CysE, which inserts into the CysK active site (11) . The C-terminal Ile Significance Contact-dependent growth inhibition (CDI) systems produce toxins that inhibit competing bacteria and immunity proteins that protect against self-inhibition. The CDI toxin deployed by Escherichia coli 536 is a nuclease that only cleaves transfer RNA (tRNA) molecules when bound to the biosynthetic enzyme O-acetylserine sulfhydrylase (CysK). Here, we present crystal structures of the activated CysK/toxin binary complex and the neutralized CysK/toxin/immunity protein ternary complex. CysK significantly increases toxin thermostability and promotes its interaction with tRNA substrates. Collectively, our results indicate that CysK stabilizes the toxin fold, thereby organizing the nuclease active site for substrate recognition and catalysis. We propose that the E. coli 536 toxin may need to unfold when transferred between bacteria and that its interaction with CysK could ensure reactivation after entry into target cells.
residue of CysE is particularly critical and interacts with the CysK active site using the same contacts as the enzyme substrate O-acetylserine (12, 13) . Although CysK and CysM share 58% sequence identity, CysE does not interact stably with the CysM isoenzyme (14) . The CdiA-CT EC536 toxin carries a C-terminal Gly-Tyr-Gly-Ile (GYGI) peptide motif that appears to mimic the Gly-Asp-Gly-Ile (GDGI) tail of E. coli CysE. Moreover, O-acetylserine blocks the binding of both CysE and CdiA-CT EC536 to CysK (8, 10) , indicating that CdiA-CT EC536 also inserts its C-terminal tail into the CysK active-site cleft. Remarkably, other proteins mimic CysE to bind CysK (15) . In Bacillus species, the CymR transcription factor uses its C-terminal Met-Phe-Tyr-Ile tail to bind CysK, and modulation of this interaction controls the cys regulon (16) . Perhaps more intriguing is EGL-9, an O 2 -sensing prolyl hydroxylase from Caenorhabditis elegans that binds a CysK homolog (CYSL-1) using a C-terminal Ile residue (17) . The resulting complex senses O 2 tension indirectly through hydrogen sulfide, which accumulates during hypoxia. Sulfide binds the CYSL-1 active site and displaces the C terminus of EGL-9. Once liberated, EGL-9 hydroxylates HIF-1 to initiate transcriptional responses to hypoxia (17) . Thus, CysK and its homologs have been coopted to regulate gene expression in bacteria and eukaryotes.
To gain mechanistic insight into toxin activation, we solved crystal structures of the CdiA-CT EC536 toxin in binary complex with CysK, and in ternary complex with CysK and CdiI EC536 immunity protein. The nuclease domain forms a small four-helix bundle with no structural similarity to other known RNase families. Two toxins bind to each CysK homodimer, and the C-terminal GYGI peptide of the nuclease inserts into the CysK active-site cleft as predicted by previous studies (8) . Structure-guided mutagenesis revealed a putative catalytic triad of Asp155, His178, and Glu181 in the nuclease domain. The predicted nuclease active site is occluded by immunity protein in the CysK/CdiA-CT/CdiI EC536 structure, suggesting that CdiI EC536 blocks the binding of tRNA substrates to the toxin. Intriguingly, Ntox28 homologs from Gram-positive bacteria lack the C-terminal GYGI motif, suggesting that they do not require CysKmediated activation. We tested this prediction using Tox28
Rlac from Ruminococcus lactaris and confirmed that the domain possesses CysK-independent tRNase activity. Moreover, Tox28
Rlac is significantly more stable to thermal denaturation than CdiA-CT EC536 and possesses intrinsic tRNA-binding activity. By contrast, CysK is required for tRNA binding to CdiA-CT
EC536
. Collectively, these findings suggest that CysK is recruited to stabilize CdiA-CT EC536 , thereby organizing the active site to promote substrate binding and catalysis.
Results
We generated a binary complex of CysK bound to inactive CdiA-CT EC536 toxin that contains the His178Ala mutation (numbered from Val1 of the VENN motif). The CysK/CdiA-CT(H178A) EC536 complex crystallized in space group P4 1 , and the structure was solved to 2.7 Å resolution (Table S1 ). Like other O-acetylserine sulfhydrylases (18), E. coli CysK is homodimeric and contains a pyridoxal 5′-phosphate (PLP) cofactor in Schiff-base linkage to Lys42. CysK in the binary complex has an "open" active-site conformation, similar to the structure of unliganded CysK from Salmonella Typhimurium (rmsd of 0.5 Å over all 312 α-carbons) (18) . Thus, the toxin does not induce the "closed" conformation observed when CysK contains substrate covalently bound to PLP in the active site (19) . As we have found in other CdiA-CT toxin structures (5, 6, 20) , only the C-terminal nuclease domain (residues Lys127-Ile227) is resolved in the final model. The CdiA-CT EC536 nuclease domain consists of four α-helices. Three long helices (α1, α3, and α4) form a bundle capped by the shorter helix α2 (Fig. 1A) . Helices α2 and α3 are connected by the long flexible loop L2, which was modeled predominately as Ala residues. Two CdiA-CT EC536 nuclease domains bind to the CysK dimer, but the toxins make no contact with one another (Fig. 1A) , suggesting that they bind independently. The C-terminal tail of the nuclease domain inserts into the CysK active site, with the GYGI peptide backbone forming a network of hydrogen bonds (H-bonds) with CysK ( Fig.  1B and Table S2 ). The toxin's C-terminal Ile227 residue is positioned in close proximity to the active-site PLP and forms H-bonds with Thr69, Asn72, Thr73, and Gln143 of CysK ( Fig. 1 B and C) . These latter contacts have been observed in structures of CysE C-terminal peptides bound to the CysK active site (13, 21, 22) . The side-chain of Tyr225 H-bonds to CysK residues Thr95 and Asp164 ( Fig. 1B and Table S2 ). The GYGI tail interactions are buttressed by additional H-bonds and salt bridges emanating from toxin helices α2, α3, and α4 (Table S2) . Residues within α2 (Leu160, Ile156, Ile157, and Met163), α3 (Met179 and Leu186), and α4 (Leu222) also form hydrophobic interactions with CysK, and the toxin helical bundle exploits shape complementarity to fit into the CysK active-site cleft (Fig. 1D) . Overall, the complex interface is 1,280 Å 2 , burying 9.2% and 19.4% of the solvent-accessible surface areas of CysK and CdiA-CT EC536 , respectively. E. coli CysK and CysM share related structures (rmsd of 1.8 Å over 285/292 α-carbons) but differ significantly in the loop L17 region at the entrance of the active-site cleft ( Fig. 2A) . CysK contains 16 extra residues in loop L17 that introduce an additional α-helix (α7°) ( Fig. 2A and Fig. S1 ). The differences in loop L17 have profound effects on the landscape and electrostatic surface potential of each active-site cleft (Fig. 2B) (12, 23) . Superimposition of CdiA-CT EC536 onto the CysM structure produces several clashes with the C-terminal GYGI peptide (Fig. 2B) . Moreover, the CysM active site contains no hydrophobic pockets capable of accommodating the side-chains of toxin residues Ile227 and Tyr225. Residues Lys223 and Gly224 at the end of toxin helix α4 and Met179 and Gln183 within helix α3 each clash with the surface of CysM loop L17 (Fig. 2C) . Thus, CdiA-CT EC536 and CysE both exploit differences in loop L17 sequence and structure to bind CysK specifically.
The CdiI EC536 immunity protein binds to CysK/CdiA-CT EC536 , forming a neutralized ternary complex (8) . The crystal structure of this ternary complex shows that immunity protein binds to each toxin to form a dimer of heterotrimers (Fig. 3A) . The CysK and CdiA-CT EC536 structures and interactions are very similar in the binary and ternary complexes (rmsd of 0.25 Å over all α-carbons; Table S3 ), indicating that the immunity protein does not grossly alter toxin conformation. CdiI EC536 is a single domain composed of one 3 10 -and eight α-helices arranged in four stacked layers to form an antiparallel spiral (Fig. 3B) . A DALI server (24) search indicates that CdiI EC536 does not share structural homology with other known antitoxins or immunity proteins (Table S4 ). The immunity protein interacts exclusively with the nuclease domain of CdiA-CT EC536 and makes no contacts with CysK (Fig. 3A) . Flexible loop L2 of the nuclease domain interacts extensively with CdiI EC536 , stabilizing the loop and allowing its side-chains to be fully resolved in the ternary complex (Fig. 3C) . Fifteen H-bonds and ion pairs connect CdiA-CT EC536 helix α3 to helices α2*, α4*, and α6* of CdiI EC536 ( Fig. 2C and Table S5 ). Additionally, toxin residue Trp176 from loop L2 fits into a hydrophobic pocket formed by Ile8, Ile11, Leu23, Trp26, Phe27, and Leu51 of CdiI EC536 (Fig. 3D) , respectively. Comparisons of different Ntox28 domains and their predicted immunity proteins reveal that many of the interacting residues are conserved throughout the toxin/immunity family (Fig. S2) . A DALI search indicates that the CdiA-CT EC536 nuclease domain does not share structural homology with other known RNases (Table S4 ). The domain also lacks an obvious tRNA-binding pocket, but previous work suggests that His178 is an active-site residue ( Fig. 4A and Fig. S2A ) (8) . Therefore, we used site-directed mutagenesis to probe residues in the vicinity of His178 for roles in growth inhibition. CdiA-CT EC536 expression plasmids were introduced into E. coli cysK + and ΔcysK strains, and transformants were selected on media supplemented with either glucose to suppress, or arabinose to induce, toxin expression. The WT construct was lethal when introduced into cysK + cells under any condition but had no effect on ΔcysK cell growth even when induced with arabinose (Fig. 4B) . This result illustrates cysKdependent toxicity for comparison with mutated CdiA-CT EC536 variants. CdiA-CT EC536 residues Asp155 and Glu181 cluster near His178 (Fig. 4A ) and are completely conserved in known Ntox28 domains (Fig. S2A) , suggesting functional importance. Asp155Ala and Glu181Ala mutations abolished growth inhibition activity, showing the same phenotype as the His178Ala mutation (Fig. 4B) . Thr185 is also positioned near His178, but mutation of this residue had no discernible effect on toxicity (Fig. 4B) . Asn149, Lys152, and Arg187 were tested for potential contributions to tRNA binding, but mutations at these positions also had no effect on growth inhibition (Fig. 4B) . Lastly, we examined loop L2 residue Trp176, which is located at the junction with helix α3 near the putative catalytic triad of Asp155, His178, and Glu181 (Fig. 4A) . Aromatic residues are conserved at this position in Ntox28 domains (Fig. S2A) , suggesting that Trp176 may contribute to tRNA substrate recognition. The Trp176Ala expression plasmid was maintained stably in cysK + cells under repressive conditions, but cell growth was inhibited upon induction with arabinose (Fig. 4B) . In vitro nuclease assays with purified toxins showed that the Asp155Ala, His178Ala, and Glu181Ala mutations each blocked activity (Fig. 4C) . Additionally, we found that CdiA-CT EC536 anticodon nuclease activity requires divalent cations (Fig. S3A) , suggesting that Asp155 and Glu181 may contribute to catalysis by coordinating Mg
2+
. The Thr185Ile mutation had a minor effect, but the activity of the Trp176Ala variant was significantly attenuated (Fig. 4C) . To exclude the possibility that the mutations interfere with CysK binding, we confirmed that each CdiA-CT EC536 variant interacts with CysK-His 6 using Ni
-affinity copurification (Fig. S3B) . Together, these results suggest that Asp155, His178, and Glu181 form a catalytic triad required for tRNase activity.
Several CdiA proteins carry Ntox28 domains, and these toxins are also found at the C terminus of Tyr-Asp-repeat and WXG100 proteins from Gram-positive bacteria (4). Gram-positive Ntox28 domains have insertions in loop L3 and lack C-terminal G(Y/H) GI sequences (Fig. S2A) , suggesting that they do not interact with CysK. We tested this prediction using the Ntox28/immunity protein pair encoded by the RUMLAC_00243/00244 loci of R. lactaris ATCC 29176. We first confirmed that Tox28
Rlac inhibits cell growth using controlled proteolysis to degrade ssrA(DAS)-tagged Imm Rlac immunity protein, thereby liberating the toxin domain inside E. coli cells. Tox28
Rlac inhibited the growth of both cysK + and ΔcysK cells whereas expression of CdiA-CT EC536 using the same approach had no inhibitory effect on ΔcysK cells (Fig. 5A ). We also found that CysK does not bind to Tox28
Rlac with high affinity although the toxin forms a stable complex with the Imm Rlac immunity protein (Fig. 5B) . In vitro nuclease assays revealed that purified Tox28
Rlac cleaves tRNA, but, in contrast to CdiA-CT EC536 , the addition of CysK failed to stimulate nuclease activity (Fig. 5C) nuclease domain is small and lacks an extensive hydrophobic core, we explored the possibility that CysK stabilizes the toxin fold. We first monitored the stability of each toxin to thermal denaturation using circular dichroism (CD) spectroscopy. These analyses revealed that the melting temperature (T m ) for Tox28 Rlac is ∼10°C higher than that of the CdiA-CT EC536 toxin (Table S6 and Fig.  S4A ). We then examined the thermostability of the CysK/CdiA-CT EC536 complex using both CD spectroscopy and differential scanning fluorimetry (DSF). Both experimental approaches showed that the CysK/CdiA-CT EC536 complex has a T m of ∼66°C, which is very similar to the value obtained for Tox28 Rlac (Table S6 and Fig.  S4A ). The T m for isolated CysK was ∼58°C (Table S6) , showing that the complex is more stable than the individual components. We also found that the CdiI EC536 and Imm Rlac immunity proteins have a significant stabilizing effect, effectively increasing the T m for each toxin (Table S6 and Fig. S4B ). These data indicate that CdiA-CT EC536 is intrinsically less stable than Tox28 Rlac but exhibits comparable thermostability when bound to CysK.
Finally, we tested whether CysK promotes the binding of tRNA substrates to CdiA-CT EC536 . We expressed His 6 epitope-tagged CdiA-CT(H178A) EC536 and/or CysK in E. coli and then treated the cell lysates with formaldehyde to cross-link tRNA to the proteins. Analysis of complexes isolated from these reactions revealed that tRNA was preferentially cross-linked when both CysK and CdiA-CT EC536 were present in the lysates (Fig. 6A) . This interaction appears to reflect physiologically relevant substrate binding because coexpression of CdiI EC536 reduced tRNA cross-linking to the CysK/ CdiA-CT EC536 complex (Fig. 6B) . This latter result suggests that immunity protein blocks nuclease activity by occluding the tRNAbinding site. Because Tox28
Rlac is an autonomous tRNase, we predicted that it should exhibit intrinsic tRNA-binding activity. We generated a His 6 -tagged version of Tox28
Rlac that contains the His114Ala mutation to ablate nuclease activity and tested whether it binds substrate. Substantial amounts of tRNA copurified with the inactive Tox28
Rlac domain, even without formaldehyde cross-linking (Fig. 6C) . The interaction between tRNA and Tox28
Rlac was effectively blocked by cognate Imm Rlac immunity protein (Fig. 6C ), again suggesting that the immunity protein binds over the nuclease active site. Together, these results indicate that CysK stabilizes CdiA-CT
EC536
, rendering the nuclease domain competent to bind substrate. By contrast, the Tox28
Rlac domain is intrinsically stable and binds tRNA without assistance from CysK.
Discussion
These results provide several insights into CdiA-CT EC536 toxin activation. As predicted from prior work (8) , the crystal structures show that the toxin inserts its C-terminal GYGI tail into the CysK active site and anchors the complex. The toxin's C-terminal carboxylate forms important H-bond contacts with conserved CysK active-site residues in the substrate-binding loop, and these same interactions are observed in the structures of CysE peptides bound to CysK from Haemophilus influenzae and Arabidopsis thaliana (21, 22) . The C-terminal Ile residues of CdiA-CT EC536 and CysE exploit the same hydrophobic and H-bond contacts as O-acetylserine to bind the CysK active site (19) . Although C-terminal Ile residues are critical for binding, substitutions are tolerated at other positions within the peptide tail. Salsi et al. have shown that CysK binds CysE peptides altered at the penultimate and antepenultimate positions (13) . This plasticity accommodates the natural variation in CysE tail sequences and accounts for the ability of E. coli CysK to bind both GDGI and GYGI motifs with high affinity. Structures are not available for the full cysteine synthase complex; thus, it is unclear whether CdiA-CT EC536 mimics other features of CysE. However, we note that the CysE structure differs markedly from CdiA-CT EC536 . The CysE C-terminal domain forms a β-helix that terminates in a flexible tail (25) . Further, the β-helical domain mediates trimerization, and two CysE trimers interact to form a larger homohexameric complex (25) . If the β-helical domains of CysE interact with CysK, then the contacts are likely to be distinct from those observed with the CdiA-CT EC536 α-helical bundle. The same uncertainties apply to other "moonlighting" partners of CysK for which no structural information is available (15) . It is intriguing that CysK has been repeatedly recruited as a binding partner by disparate proteins. Perhaps this phenomenon reflects the antiquity and immutability of cysteine synthase complexes, which remain remarkably similar in extant bacteria and plants. From the perspective of CDI, the ubiquity and conserved active-site architecture of CysK ensure that toxins can be activated in a broad range of bacteria.
The structure of the CdiA-CT EC536 nuclease domain is unique, and its catalytic mechanism seems to be distinct from other anticodon nucleases. Colicins E5 and D are the only other anticodon nucleases for which structures are available (26) . The nuclease domains of colicins E5 and D share an α/β fold that characterizes the Barnase-EndoU-ColicinE5/D-RelE (BECR) family of RNases (4). Like barnase, colicins E5 and D are metal-independent nucleases that abstract a proton from the 2´-hydroxyl to initiate an intramolecular attack on the scissile phosphodiester bond (26) . By contrast, CdiA-CT EC536 has divalent cation-dependent nuclease activity, which is usually associated with a hydrolytic mechanism. Mutational analyses support a role for CdiA-CT EC536 residues Asp155, Glu181, and His178 in catalysis. Asp155 and Glu181 are candidates to coordinate Mg 2+ , which could either activate water for hydrolysis or stabilize hydroxide ions generated by His178 acting as a general base (27) . Another difference between colicins E5/D and CdiA-CT EC536 is the lack of a defined substrate-binding pocket in the latter nuclease. Several observations suggest that flexible loop L2 participates in tRNA binding. L2 is conserved among Ntox28 family members and always contains hydrophobic residues adjacent to His178. Our results show that Trp176 is important, but not strictly required, for CdiA-CT EC536 activity. We hypothesize that Trp176 stacks onto nucleobases within the tRNA anticodon loop. This mode of recognition is common among aminoacyl-tRNA synthetases, which bind cognate tRNAs using conserved hydrophobic/aromatic residues that stack onto the first and second nucleotides of the anticodon (28) .
Finally, we propose that CysK promotes CdiA-CT EC536 nuclease activity by stabilizing the toxin's fold. The CdiA-CT EC536 helical bundle is relatively small and lacks an extensive hydrophobic core. Consequently, CdiA-CT EC536 has relatively low thermostability, raising the possibility that thermal fluctuations disrupt the active site by splaying the helices. CysK anchors toxin helices α2 and α3, thereby approximating Asp155 and Glu181 to coordinate Mg 2+ . The CysK scaffold also anchors the ends of loop L2, which we propose is important for substrate binding. In support of this model, we find that tRNA interacts with the CysK/CdiA-CT EC536 complex, but not with the individual components. CdiI EC536 blocks the interaction with substrate, strongly suggesting that the immunity protein occludes the nuclease active site. The extensive contact between loop L2 and CdiI
EC536
, together with the sequestration of Trp176 within the immunity protein, is consistent with this model. Although CysK is critical for CdiA-CT EC536 nuclease activity, related toxins from Gram-positive bacteria probably do not require extrinsic activation because purified Tox28 domain from R. lactaris has tRNase activity in vitro. Ntox28 domains are typically found at the C terminus of proteins that mediate interbacterial competition (4, (29) (30) (31) . For example, the R. lactaris Tox28
Rlac domain is part of a larger EC536 were treated with formaldehyde, and cross-linked nucleoprotein complexes were purified by Ni 2+ -affinity chromatography. Purified samples were analyzed by SDS/PAGE (Top) and 50% urea PAGE (Bottom) to visualize proteins and nucleic acid, respectively. (B) CdiI EC536 blocks tRNA cross-linking to CysK/CdiA-CT EC536 . E. coli cell lysates containing CysK-His 6 , CysK-His 6 /CdiA-CT(H178A) EC536 , and CysK-His 6 /CdiA-CT(H178A)/CdiI EC536 were treated with formaldehyde where indicated, followed by Ni 2+ -affinity chromatography, and gel analysis as described in A. (C) Tox28
Rlac interacts stably with tRNA substrate. Cell lysates containing His 6 -Tox28(H114A) Rlac and Imm Rlac were treated as described above. To ascertain cross-linking specificity, EF-Tu-His 6 was also purified and analyzed for tRNA binding. rearrangement hotspot (Rhs) repeat protein. Rhs and related YDrepeat proteins deliver toxic nuclease domains into both Gramnegative and Gram-positive bacteria (32, 33) . Further, the Ntox28 homolog from Geobacillus sp. strain Y412MC10 (GYMC10_1092) is linked to an N-terminal ESAT-6-like domain, which is predicted to guide export through type VII secretion systems (4, 29) . Given that all Ntox28 domains function in intercellular competition, perhaps the mechanism of toxin delivery into Gram-negative bacteria accounts for the relative instability of CdiA-CT
. We recently discovered that CDI toxins hijack a variety of inner-membrane proteins to enter the target-cell cytoplasm (9) . If CdiA-CT domains must unfold during this translocation step, then there may be a selective pressure for toxins with low global stability.
Methods
Plasmid constructions (Table S7) , site-directed mutagenesis, and protein purification procedures are described in SI Methods (8) . Protein crystallization was previously described (6) . Briefly, crystals were grown by the hanging-drop, vapor-diffusion method at room temperature against a reservoir containing 0.2 M NaSO 4 , 0.1 M Bis-Tris propane (pH 7.9), and 20% (wt/vol) PEG 3350, for the binary complex, and 0.1 M sodium cacodylate (pH 7.1), 0.2 M ammonium sulfate, and 17% (wt/vol) PEG-8000, for the ternary complex. Structural models were determined as described (6) . Protein binding affinities were calculated using biolayer interferometry, and thermal stabilities were determined by DSF and CD spectroscopy as outlined in SI Methods. Nuclease activity assays were performed as described (8) with modifications outlined in SI Methods. Nucleoprotein cross-linking was performed as described in SI Methods.
